Another finding is that in breast cancer samples with lymph node metastasis, the mutation hotspots in TP53 are only discretely distributed in the p53 (DNA-binding) domain, which is consistent with the previous study that most cancer somatic mutations are located in the DNA-binding domain20. This evidence concerns the gene TP53 and breast carcinoma.